Multiechinocandin- and multiazole-resistant Candida parapsilosis solates serially obtained during therapy for prosthetic valve endocarditis

被引：178

作者：

Moudgal, V ^{[1
]}

Little, T ^{[1
]}

Boikov, D ^{[1
]}

Vazquez, JA ^{[1
]}

机构：

[1] Wayne State Univ, Sch Med, Div Infect Dis, Detroit, MI USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 02期

关键词：

D O I：

10.1128/AAC.49.2.767-769.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Echinocandins are approved for the treatment of candidal infections. In vitro they have been shown to be less potent against strains of Candida parapsilosis than against other Candida spp. This is the first case report describing the development of a secondary multidrug (echinocandin-azole)-resistant Candida strain during therapy.

引用

页码：767 / 769

页数：3

共 20 条

[1]

ABUELTEEN K, 1989, MYCOSES, V32, P551, DOI 10.1111/j.1439-0507.1989.tb02180.x

[2] Randomized, double-blind, Multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases [J].

Arathoon, EG ;

Gotuzzo, E ;

Noriega, LM ;

Berman, RS ;

DiNubile, MJ ;

Sable, CA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) :451-457

[3] In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance [J].

Bachmann, SP ;

Patterson, TF ;

López-Ribot, JL .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) :2228-2230

[4] Echinocandins: a new class of antifungal [J].

Denning, DW .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (06) :889-891

[5] An outbreak of Candida parapsilosis prosthetic valve endocarditis [J].

Diekema, DJ ;

Messer, SA ;

Hollis, RJ ;

Wenzel, RP ;

Pfaller, MA .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 29 (03) :147-153

[6] In vitro activity of micafungin (FK-463) against Candida spp.:: Microdilution, time-kill, and postantifungal-effect studies [J].

Ernst, EJ ;

Roling, EE ;

Petzold, CR ;

Keele, DJ ;

Klepser, ME .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (12) :3846-3853

[7]

Espinel-Ingroff Ana, 2003, Revista Iberoamericana de Micologia, V20, P121

[8] Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections [J].

Groll, AH ;

Walsh, TJ .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (08) :1545-1558

[9]

KEATING GM, 2002, CASPOFUNGIN DRUGS, V61, P1121

[10] Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent [J].

Koss, T ;

Bagheri, B ;

Zeana, C ;

Romagnoli, MF ;

Grossman, ME .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (06) :945-947

← 1 2 →